Caleb J Fan1, Hung-Lun Chien2, Matthew J Weiss3, Jin He3, Christopher L Wolfgang3, John L Cameron3, Timothy M Pawlik4, Martin A Makary3. 1. Department of Otolaryngology, Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA. caleb.fan@mountsinai.org. 2. Minimally Invasive Therapies Group, Medtronic Inc., Mansfield, MA, USA. 3. Department of Surgery, The Johns Hopkins University, Baltimore, MD, USA. 4. Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Abstract
BACKGROUND: Despite strong evidence demonstrating the clinical and economic benefits of minimally invasive surgery (MIS), utilization of MIS in the Medicare population is highly variable and tends to be lower than in the general population. We sought to compare the post-operative and economic outcomes of MIS versus open surgery for seven common surgical procedures in the Medicare population. METHODS: Using the 2014 Medicare Provider Analysis and Review Inpatient Limited Data Set, patients undergoing bariatric, cholecystectomy, colectomy, hysterectomy, inguinal hernia, thoracic, and ventral hernia procedures were identified using DRG and ICD-9 codes. Adjusting for patient demographics and comorbidities, the odds of complication and all-cause 30-day re-admission were compared among patients undergoing MIS versus open surgery stratified by operation type. A generalized linear model was used to calculate the estimated difference in length of stay (LOS), Medicare claim cost, and Medicare reimbursement. RESULTS: Among 233,984 patients, 102,729 patients underwent an open procedure versus 131,255 who underwent an MIS procedure. The incidence of complication after MIS was lower for 5 out of the 7 procedures examined (OR 0.36-0.69). Re-admission was lower for MIS for 6 out of 7 procedures (OR 0.43-0.87). MIS was associated with shorter LOS for 6 procedures (point estimate range 0.35-2.47 days shorter). Medicare claim costs for MIS were lower for 4 (range $3010.23-$4832.74 less per procedure) and Medicare reimbursements were lower for 3 (range $841.10-$939.69 less per procedure). CONCLUSIONS: MIS benefited Medicare patients undergoing a range of surgical procedures. MIS was associated with fewer complications and re-admissions as well as shorter LOS and lower Medicare costs and reimbursements versus open surgery. MIS may represent a better quality and cost proposition in the Medicare population.
BACKGROUND: Despite strong evidence demonstrating the clinical and economic benefits of minimally invasive surgery (MIS), utilization of MIS in the Medicare population is highly variable and tends to be lower than in the general population. We sought to compare the post-operative and economic outcomes of MIS versus open surgery for seven common surgical procedures in the Medicare population. METHODS: Using the 2014 Medicare Provider Analysis and Review Inpatient Limited Data Set, patients undergoing bariatric, cholecystectomy, colectomy, hysterectomy, inguinal hernia, thoracic, and ventral hernia procedures were identified using DRG and ICD-9 codes. Adjusting for patient demographics and comorbidities, the odds of complication and all-cause 30-day re-admission were compared among patients undergoing MIS versus open surgery stratified by operation type. A generalized linear model was used to calculate the estimated difference in length of stay (LOS), Medicare claim cost, and Medicare reimbursement. RESULTS: Among 233,984 patients, 102,729 patients underwent an open procedure versus 131,255 who underwent an MIS procedure. The incidence of complication after MIS was lower for 5 out of the 7 procedures examined (OR 0.36-0.69). Re-admission was lower for MIS for 6 out of 7 procedures (OR 0.43-0.87). MIS was associated with shorter LOS for 6 procedures (point estimate range 0.35-2.47 days shorter). Medicare claim costs for MIS were lower for 4 (range $3010.23-$4832.74 less per procedure) and Medicare reimbursements were lower for 3 (range $841.10-$939.69 less per procedure). CONCLUSIONS: MIS benefited Medicare patients undergoing a range of surgical procedures. MIS was associated with fewer complications and re-admissions as well as shorter LOS and lower Medicare costs and reimbursements versus open surgery. MIS may represent a better quality and cost proposition in the Medicare population.
Authors: Tamara M Atkinson; George D Giraud; Brandon M Togioka; Daniel B Jones; Joaquin E Cigarroa Journal: Circulation Date: 2017-02-14 Impact factor: 29.690
Authors: Jason D Wright; Alfred I Neugut; Elizabeth T Wilde; Donna L Buono; Wei-Yann Tsai; Dawn L Hershman Journal: J Oncol Pract Date: 2012-06-19 Impact factor: 3.840
Authors: Brett L Ecker; Lindsay E Y Kuo; Kristina D Simmons; John P Fischer; Jon B Morris; Rachel R Kelz Journal: Surg Endosc Date: 2015-06-20 Impact factor: 4.584
Authors: G Soliani; A De Troia; M Portinari; S Targa; P Carcoforo; G Vasquez; P M Fisichella; C V Feo Journal: Hernia Date: 2017-04-10 Impact factor: 4.739
Authors: Andre da Luz Moreira; Ravi P Kiran; Hasan T Kirat; Feza H Remzi; Daniel P Geisler; James M Church; Thomas Garofalo; Victor W Fazio Journal: Surg Endosc Date: 2009-12-24 Impact factor: 4.584
Authors: Kota Sahara; Anghela Z Paredes; Diamantis I Tsilimigras; J Madison Hyer; Katiuscha Merath; Lu Wu; Rittal Mehta; Eliza W Beal; Susan White; Itaru Endo; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2019-02-04 Impact factor: 3.452
Authors: Tarik K Yuce; Ryan J Ellis; Jeanette Chung; Ryan P Merkow; Anthony D Yang; Nathaniel J Soper; Edward J Tanner; Edward M Schaeffer; Karl Y Bilimoria; Gregory B Auffenberg Journal: J Surg Oncol Date: 2020-01-22 Impact factor: 3.454